Investment process: Research-intensive stock picking
BlackRock’s European Equity team comprises 21 fund managers and analysts. There is no house view to be adhered to. The structure beneath Nigel Bolton, the head of the team, is flat and everyone is involved in research. Analysis is conducted by sector not country; there are seven research sectors headed by generalist fund managers and supported by specialised analysts (business services [headed by Devlin], capital investment, consumer, commodities, financials, healthcare and infrastructure). The differentiation in the process is that it is flexible in nature with no inherent portfolio bias to growth, income or value. The manager’s natural style is to hold high-conviction positions in quality, long-duration companies. However, the portfolio also contains restructuring and value names. Currently, the portfolio has more of a growth than a value bias, but this is a reflection of what is working in the market, as well as the manager’s style. There is no permanent bias in the fund.
To generate ideas, a series of screens are run, which change depending on the current market relevance. The team does not adopt a maintenance research strategy (ie covering every stock in the market), preferring to focus on ‘best ideas’. Along with generic and specific screens, the importance of company meetings is stressed. As the world’s largest asset manager, BlackRock has good access to company managements; the team has c 850 meetings each year. All research is proprietary; positions are not taken on the basis of sell-side research, although this may be used as an additional information source. The macro environment is considered regarding the sourcing of ideas and portfolio positioning, but all investment is on a bottom-up basis.
Potential portfolio investments undergo in-depth company analysis. There is a formal research pipeline formed by company access, analyst experience and in-house screens. This is updated once a fortnight and limited to one or two stocks per sector at a time. Senior portfolio managers allocate the research hours on the back of the pipeline. A due date is assigned for the analyst to deliver the research ideas. The advantages of the approach are depth of knowledge in the team, swift turnaround of ideas and communication to the rest of the team. Reports on companies researched use a common template and before presentation to the team, the analysts have usually already met with the company management. A range of valuation measures are used that are appropriate to the individual companies. A discounted cash flow valuation is generally used as a check rather than a driver; price targets are generally derived using relative multiples. Stocks are given a rating of 1 (strong buy) to 5 (short). 1 is a hard rating for a company to achieve; the portfolio typically comprises 20% 1-rated, 60% 2-rated and 20% 3-rated companies. A 3-rated company might be a long-term idea with not much happening in the short term. It would be unusual for the manager to take a new position in a company with a 3 rating. The research template is updated as or when there is a real change in the company newsflow or valuation; all portfolio holdings have a template.
Team meetings are an important element of the investment process. The whole team meets each morning to discuss market news, earnings releases, company meeting feedback, debate holdings and, if time allows, company research. Research meetings are held twice a week and may include a portfolio review, where each portfolio manager presents on a five-week rotational basis. The pipeline meeting is once a fortnight and there is a ‘top picks’ meeting once a month, where two or three potential investments are discussed. There are also formal meetings with Risk Quantitative Analysis (RQA), a well-resourced team that acts as an internal consultant about market and portfolio risk and any problems with the risk model; the managers describe it as an “intelligent overlay” on the model numbers. A team chat room is regularly used given that the team has offices in both London and Edinburgh. Members of the dealing team also contribute to the chat room.
When the portfolio is constructed there are three basic principles: risk within it is deliberate; the portfolio is appropriately diversified and positions are appropriately scaled (ensuring that a lower-conviction stock does not have an overly large weighting in the fund). There are sophisticated systems used to control risks. The internal model BFRE (a risk model similar to the widely used Barra) is factor based, taking into account beta, country, industry, stock-specific and forecast risk. Stock-specific risk should be the dominant driver of returns. Tracking error – a measure of ‘active risk’, or how much portfolio returns deviate from the benchmark – was 3.67% at the end of 2015. BRGE is actively managed and because stocks are selected on a bottom-up basis, there may be a significant deviation from the benchmark sector weights. Stocks may be sold when the price target is hit, if there is a better idea available, or if the investment case has changed, such as following an economic shift or from observations about the end-market. Portfolio turnover over the last three years has averaged c 90% pa; as well as new positions and complete exits, the managers may trim and add to holdings to ensure that positions remain appropriately sized.
Current portfolio positioning
At the end of February 2016, the portfolio had 54 holdings, in the middle of the typical range of 45 to 65. 5.4% of the portfolio was invested in developing Europe and there were no unquoted investments. The top 10 holdings accounted for 31.6% of the portfolio compared to 34.5% a year earlier. Four holdings were represented in each time period.
Exhibit 5: Portfolio breakdown by market cap as at 31 December 2015 (%)
|
Portfolio* |
Benchmark |
Difference |
Greater than €25bn |
34.0 |
52.6 |
-18.6 |
€10 to €25bn |
35.1 |
25.4 |
9.7 |
€5 to €10bn |
16.3 |
13.6 |
2.7 |
€2 to €5bn |
12.4 |
7.7 |
4.7 |
Less than €2bn |
4.4 |
0.7 |
3.7 |
Total |
102.2 |
100.0 |
2.2 |
Source: BlackRock Greater Europe Investment Trust. Note: *Includes 2.2% gearing.
In the current low growth environment, portfolio holdings are typically companies that can demonstrate high single-digit/double-digit earnings growth without being overly tied to the economy, which the manager refers to as “stocks that are driven on their own merits”. There are also turnaround names in the portfolio such as Adidas, selected income opportunities, for example in insurance and real estate, and businesses with attractive valuations such as infrastructure. Adidas has struggled in terms of market share as a result of poor management of its distribution network. In the US it has been underrepresented at key retailer Foot Locker and has seen additional competitive pressure from Under Armour. A new CEO and management are in place, which has reinvigorated the business and led to the potential for higher margins.
Exhibit 6: Portfolio sector exposure vs benchmark (%)
|
Portfolio end February 2016 |
Portfolio end February 2015 |
Change |
Index weight |
Active weight vs index |
Trust weight/ index weight |
Financials |
28.2 |
33.8 |
-5.5 |
21.3 |
7.0 |
1.3 |
Industrials |
19.2 |
15.6 |
3.6 |
12.2 |
7.0 |
1.6 |
Healthcare |
17.5 |
8.2 |
9.3 |
12.3 |
5.3 |
1.4 |
Consumer goods |
13.3 |
18.7 |
-5.4 |
19.5 |
-6.2 |
0.7 |
Consumer services |
9.0 |
7.1 |
1.9 |
7.8 |
1.2 |
1.2 |
Technology |
8.5 |
6.3 |
2.2 |
3.5 |
4.9 |
2.4 |
Telecommunications |
4.3 |
2.9 |
1.5 |
5.0 |
-0.6 |
0.9 |
Basic materials |
0.0 |
4.9 |
-4.9 |
7.0 |
-7.0 |
0.0 |
Oil & gas |
0.0 |
0.0 |
0.0 |
7.5 |
-7.5 |
0.0 |
Utilities |
0.0 |
2.5 |
-2.5 |
4.0 |
-4.0 |
0.0 |
|
100.0 |
100.0 |
|
100.0 |
|
|
Source: BlackRock Greater Europe Investment Trust, Edison Investment Research
The largest increase in sector exposure over the last 12 months has been a 9.3 percentage point increase in healthcare. The sector was weak in 2015 due to criticism about aggressive pharmaceutical price increases; but is more exposed to developed markets than the more challenging emerging markets. Top 10 holding Novo Nordisk is a high-conviction idea; earlier in 2016, the share price fell by c 20% on no newsflow and with no change in operating earnings, but it has subsequently rallied by more than 20% from the local trough. At the Q415 results, 10% mid-term local currency operating profits growth guidance was maintained, which the manager thinks is too conservative. Novo Nordisk launched Tresiba, a next-generation insulin treatment, which is proving to be superior to the competition, so is likely to see improved labelling and hence higher volumes.
There are three new healthcare positions in the portfolio, all of which offer mid- to high-single digits earnings growth on mid- to high-teens forward P/E multiples, seen by the manager as attractive in the current market environment:
■
Fresenius Medical Care (dialysis and healthcare services) – is growing revenue at mid-single digits (6% volume +1% pricing). The company has a strong franchise and is undergoing a cost-cutting programme. On its recent earnings conference call, management reiterated guidance for accelerating revenue and net income growth in 2016.
■
William Demant (hearing aids) – the stock has an attractive valuation as a result of the general stock market move, rather than as a result of any company-specific news. There is an upcoming product cycle from mid-2016 in 2GHz hearing aids. It is a stable business; there is structural growth in demand for the company’s products due to the ageing population. It has 10% revenue growth with a forward P/E valuation of less than 20x.
■
Lonza (chemicals and drugs) – one third of the business is the outsourcing of pharmaceutical production. The FDA is currently approving more drugs, which is stretching pharmaceutical companies’ manufacturing capacity, leading to more outsourcing and hence strong growth in the business. Lonza’s other businesses in chemicals and agribusinesses are lower growth operations.
The industrial overweight is one of the largest active positions in the portfolio. Within Europe, the sector is heterogeneous, ranging for example from global cyclicals, to aerospace, to toll road operators. BRGE focuses on specific subsector exposure, such as Assa Abloy, which is a Swedish manufacturer of secure door opening systems. Within the overweight position in financials, the manager favours insurance stocks for their income and cost control and diversified financials. He is underweight banks and cautions that despite their low valuations, value stocks have continued to get cheaper.
One of the portfolio’s largest underweight positions is in consumer staples. The group is considered to be too expensive given its growth rate. A lot of the companies within the sector have exposure to emerging market consumption, which is being affected by depressed commodity prices. Selective positions are held, such as Heineken and Ontex, but a big negative position within the portfolio is a zero weight in Nestlé, which represents c 3% of the benchmark. The underweight in consumer staples is a counterpoint to the overweight positon in the healthcare sector, which the manager sees as having better growth potential and more attractive valuations.
BRGE has zero exposure to the oil and gas sector. The manager suggests that is it tough to build a strong case for the sector as free cash flow generation is unachievable with oil below $60 a barrel. This price is hard to envisage in the current macroeconomic environment. Oil and gas has outperformed the broader market year-to-date, despite the weak oil price, which is not currently reflected in the sector’s stock prices. The manager states that over the long term the major oil companies do not generate enough cash to fund their dividend payments. The trust did have a position in Lundin Petroleum (a Swedish independent oil and gas exploration and production company). However, the stock was sold in 2016 as the share price rallied on news that Statoil was taking a stake in the company; it was willing to pay a price that implied a current oil price of $60/barrel. There is also currently no exposure to the basic materials and utilities sector. Within utilities earnings are under pressure as spreads are linked to the depressed oil price. In addition, there is a lot of supply coming on stream.
Exhibit 7: Portfolio geographic exposure vs benchmark (%)
|
Portfolio end February 2016 |
Portfolio end February 2015 |
Change |
Index weight |
Active weight vs index |
Trust weight/ index weight |
France |
17.6 |
16.4 |
1.2 |
20.2 |
-2.6 |
0.9 |
Switzerland |
15.5 |
13.5 |
2.0 |
19.8 |
-4.3 |
0.8 |
Germany |
10.8 |
17.0 |
-6.2 |
18.8 |
-8.0 |
0.6 |
Denmark |
8.8 |
5.4 |
3.4 |
4.3 |
4.5 |
2.1 |
Netherlands |
8.8 |
7.3 |
1.5 |
6.7 |
2.1 |
1.3 |
Ireland |
8.3 |
6.4 |
1.9 |
0.7 |
7.6 |
12.2 |
Italy |
7.3 |
11.5 |
-4.2 |
4.7 |
2.6 |
1.6 |
Sweden |
5.2 |
6.9 |
-1.7 |
6.3 |
-1.1 |
0.8 |
Finland |
4.7 |
2.6 |
2.1 |
2.3 |
2.4 |
2.0 |
Other |
13.0 |
13.0 |
0.0 |
16.2 |
-3.2 |
0.8 |
|
100.0 |
100.0 |
|
100.0 |
|
|
Source: BlackRock Greater Europe Investment Trust, Edison Investment Research.
The above exhibit is for illustrative purposes, as the portfolio is constructed on a bottom-up stock selection basis, rather than with reference to the benchmark country weightings. However, demonstrating the active management of the portfolio, it is interesting to note underweight positions versus the three largest countries in the index: France, Switzerland and Germany.